Stay updated on Monthly AliRocumab 300mg with SYDNEY Auto-injector Clinical Trial
Sign up to get notified when there's something new on the Monthly AliRocumab 300mg with SYDNEY Auto-injector Clinical Trial page.

Latest updates to the Monthly AliRocumab 300mg with SYDNEY Auto-injector Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA new revision entry, Revision: v3.6.5, was added to the study record history, and the previous Revision: v3.6.4 was removed, reflecting an update to the record's version history.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe record history adds a new revision entry labeled v3.6.4 and removes the previous v3.6.3 entry, signaling an update to the study record's revision metadata.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry v3.6.3 was added to the Study Record History, indicating an updated version of the study record since the previous revision. The prior revision v3.6.2 is superseded by this update.SummaryDifference0.1%

- Check63 days agoChange DetectedA new revision entry (v3.6.2) was added to the record history, and the previous revision (v3.6.0) was removed from the visible history.SummaryDifference0.1%

- Check78 days agoChange DetectedThe study’s recruitment status now shows 'No longer looking for participants'. The record history adds Revision: v3.6.0 and removes the previous Revision: v3.5.5.SummaryDifference0.4%

- Check85 days agoChange DetectedA new revision entry (v3.5.5) is added to the study history, and the previous revision (v3.5.4) is removed from the history list. This updates the version history to reflect the latest submission in the record.SummaryDifference0.1%

Stay in the know with updates to Monthly AliRocumab 300mg with SYDNEY Auto-injector Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Monthly AliRocumab 300mg with SYDNEY Auto-injector Clinical Trial page.